Related references
Note: Only part of the references are listed.Treatment of Refractory Coccidioidomycosis With Voriconazole or Posaconazole
Michelle M. Kim et al.
CLINICAL INFECTIOUS DISEASES (2011)
The Public Health Impact of Coccidioidomycosis in Arizona and California
Richard F. Hector et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2011)
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis
A. Thomas et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Voriconazole Use for Endemic Fungal Infections
Alison Freifeld et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
In vitro interactions of micafungin with amphotericin B, itraconazole or fluconazole against the pathogenic phase of Penicillium marneffei
Cunwei Cao et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis
D. P. Kontoyiannis et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model
Gloria M. Gonzalez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole
DW Park et al.
BMC INFECTIOUS DISEASES (2006)
In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil
RA Cordeiro et al.
MYCOPATHOLOGIA (2006)
Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient
S Antony
CLINICAL INFECTIOUS DISEASES (2004)
Treatment of meningeal coccidioidomycosis with caspofungin
G Hsue et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Successful use of voriconazole for treatment of Coccidioides meningitis
LA Proia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole
RM Prabhu et al.
CLINICAL INFECTIOUS DISEASES (2004)
Combination and sequential antifungal therapy for invasive aspergillosis: Review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001
WJ Steinbach et al.
CLINICAL INFECTIOUS DISEASES (2003)
Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far
DP Kontoyiannis et al.
DRUG RESISTANCE UPDATES (2003)
Combination therapy in treatment of experimental pulmonary aspergillosis: Synergistic interaction between an antifungal triazole and an echinocandin
V Petraitis et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis
WR Kirkpatrick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Coccidioidomycosis: efficacy of new agents and future prospects
SC Deresinski
CURRENT OPINION IN INFECTIOUS DISEASES (2001)
Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model
GM González et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis - A randomized, double-blind trial
JN Galgiani et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
